Indaptus Therapeutics, Inc. (INDP)
3.29
-0.21
(-6.00%)
USD |
NASDAQ |
Nov 03, 14:13
Indaptus Therapeutics Enterprise Value : 454.79M for Nov. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 02, 2026 | 454.79M |
| October 30, 2026 | 400.16M |
| October 29, 2026 | 433.48M |
| October 28, 2026 | 432.14M |
| October 27, 2026 | 428.81M |
| October 26, 2026 | 433.48M |
| October 23, 2026 | 409.49M |
| October 22, 2026 | 386.84M |
| October 21, 2026 | 409.49M |
| October 20, 2026 | 382.84M |
| October 19, 2026 | 352.20M |
| October 16, 2026 | 338.87M |
| October 15, 2026 | 368.19M |
| October 14, 2026 | 282.91M |
| October 13, 2026 | 306.90M |
| October 12, 2026 | 313.56M |
| October 09, 2026 | 322.88M |
| October 08, 2026 | 304.23M |
| October 07, 2026 | 289.57M |
| October 06, 2026 | 333.54M |
| October 05, 2026 | 322.88M |
| October 02, 2026 | 305.56M |
| October 01, 2026 | 270.92M |
| September 30, 2026 | 294.90M |
| September 29, 2026 | 368.19M |
| Date | Value |
|---|---|
| September 28, 2026 | 426.81M |
| September 25, 2026 | 501.43M |
| September 24, 2026 | 521.42M |
| September 23, 2026 | 490.77M |
| September 22, 2026 | 520.08M |
| September 21, 2026 | 400.16M |
| September 18, 2026 | 461.46M |
| September 17, 2026 | 512.09M |
| September 16, 2026 | 416.15M |
| September 15, 2026 | 473.45M |
| September 14, 2026 | 406.83M |
| September 11, 2026 | 357.53M |
| September 10, 2026 | 329.55M |
| September 09, 2026 | 265.59M |
| September 08, 2026 | 234.94M |
| September 04, 2026 | 151.00M |
| September 03, 2026 | 143.01M |
| September 02, 2026 | 144.34M |
| September 01, 2026 | 139.01M |
| August 31, 2026 | 141.01M |
| August 28, 2026 | 140.34M |
| August 27, 2026 | 143.01M |
| August 26, 2026 | 140.34M |
| August 25, 2026 | 134.35M |
| August 24, 2026 | 143.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cypherpunk Technologies, Inc. | 246.74M |
| Capricor Therapeutics, Inc. | 273.82M |
| Ocugen, Inc. | 233.64M |
| Cue Biopharma, Inc. | 92.97M |
| Yarrow Bioscience, Inc. | -10.94M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.795M |
| Total Expenses (Quarterly) | 1.795M |
| EPS Diluted (Quarterly) | -0.0155 |
| Earnings Yield | -212.0% |
| Normalized Earnings Yield | -203.39 |